TD Asset Management
IRON icon

TD Asset Management’s Disc Medicine IRON Stock Holding History

TD Asset Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Sell
21,600
-8,876
-29% -$610K ﹤0.01% 1017
2026
Q1 		$1.95M Sell
30,476
-39,158
-56% -$2.72M ﹤0.01% 972
2025
Q4 		$5.53M Buy
69,634
+10,386
+18% +$878K ﹤0.01% 782
2025
Q3 		$3.92M Buy
59,248
+6,200
+12% +$369K ﹤0.01% 828
2025
Q2 		$2.81M Buy
53,048
+10,600
+25% +$498K ﹤0.01% 865
2025
Q1 		$2.11M Sell
42,448
-2,484
-6% -$138K ﹤0.01% 941
2024
Q4 		$2.85M Buy
44,932
+4,200
+10% +$243K ﹤0.01% 910
2024
Q3 		$2.04M Hold
40,732
– – ﹤0.01% 1034
2024
Q2 		$1.84M Buy
40,732
+1,468
+4% +$49.9K ﹤0.01% 1030
2024
Q1 		$2.44M Buy
39,264
+19,050
+94% +$1.24M ﹤0.01% 955
2023
Q4 		$1.17M Hold
20,214
– – ﹤0.01% 1148
2023
Q3 		$950K Buy
20,214
+14,607
+261% +$731K ﹤0.01% 1154
2023
Q2 		$249K Buy
+5,607
New +$199K ﹤0.01% 1357

Other funds holding IRON

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

TD Asset Management's IRON Position: Q2 2026 in Review

TD Asset Management reduced its Disc Medicine (IRON) stake by 29% in Q2 2026, selling an estimated $610K and leaving 21,600 shares worth $1.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1017.

TD Asset Management first reported a position in IRON in Q2 2023 and has held it in 13 quarters since. The position peaked at $5.53M in Q4 2025. 215 funds tracked by Wall St. Rank hold IRON as of Q2 2026.

  • TD Asset Management held 21,600 shares of Disc Medicine worth $1.58M as of Q2 2026.
  • TD Asset Management sold 8,876 Disc Medicine shares in Q2 2026, an estimated $610K.
  • Disc Medicine made up ﹤0.01% of TD Asset Management's portfolio in Q2 2026, its #1017 holding.
  • TD Asset Management first reported a position in Disc Medicine in Q2 2023 and has held it in 13 quarters since.
  • TD Asset Management's Disc Medicine position peaked at $5.53M in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.